1. Home
  2. SAGE vs OST Comparison

SAGE vs OST Comparison

Compare SAGE & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • OST
  • Stock Information
  • Founded
  • SAGE 2010
  • OST 2010
  • Country
  • SAGE United States
  • OST China
  • Employees
  • SAGE N/A
  • OST N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • SAGE Health Care
  • OST Technology
  • Exchange
  • SAGE Nasdaq
  • OST Nasdaq
  • Market Cap
  • SAGE 571.7M
  • OST 601.6M
  • IPO Year
  • SAGE 2014
  • OST 2022
  • Fundamental
  • Price
  • SAGE $9.08
  • OST $0.13
  • Analyst Decision
  • SAGE Hold
  • OST
  • Analyst Count
  • SAGE 18
  • OST 0
  • Target Price
  • SAGE $10.06
  • OST N/A
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • OST 28.1M
  • Earning Date
  • SAGE 07-30-2025
  • OST 08-25-2025
  • Dividend Yield
  • SAGE N/A
  • OST N/A
  • EPS Growth
  • SAGE N/A
  • OST N/A
  • EPS
  • SAGE N/A
  • OST N/A
  • Revenue
  • SAGE $47,404,000.00
  • OST $38,333,251.00
  • Revenue This Year
  • SAGE $102.21
  • OST N/A
  • Revenue Next Year
  • SAGE $43.01
  • OST N/A
  • P/E Ratio
  • SAGE N/A
  • OST N/A
  • Revenue Growth
  • SAGE N/A
  • OST N/A
  • 52 Week Low
  • SAGE $4.62
  • OST $0.12
  • 52 Week High
  • SAGE $13.47
  • OST $9.40
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 71.54
  • OST 24.47
  • Support Level
  • SAGE $9.04
  • OST $0.12
  • Resistance Level
  • SAGE $9.30
  • OST $9.40
  • Average True Range (ATR)
  • SAGE 0.15
  • OST 0.99
  • MACD
  • SAGE 0.05
  • OST -0.98
  • Stochastic Oscillator
  • SAGE 91.35
  • OST 0.10

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: